{"id":7442,"date":"2020-09-25T07:10:11","date_gmt":"2020-09-25T14:10:11","guid":{"rendered":"https:\/\/rakuten-med.com\/us\/?post_type=press_releases&#038;p=7442"},"modified":"2022-04-19T21:26:18","modified_gmt":"2022-04-20T04:26:18","slug":"rakuten-medical-japan-announces-marketing-approval-of-akalux-iv-infusion-250mg-and-bioblade-laser-system-from-the-ministry-of-labour-health-and-welfare-in-japan-for-locoregional-cancer-tr","status":"publish","type":"press_releases","link":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/09\/25\/7442\/","title":{"rendered":"Rakuten Medical Japan Announces Marketing Approval of Akalux\u00ae IV Infusion 250mg and BioBlade\u00ae Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment"},"content":{"rendered":"<p><span class=\"xn-location\">SAN MATEO, Calif.<\/span>,\u00a0<span class=\"xn-chron\">Sept. 25, 2020<\/span>\u00a0\/PRNewswire\/ &#8212; Rakuten Medical Inc. is proud to announce that its wholly owned subsidiary Rakuten Medical Japan K.K. has received marketing approval in\u00a0<span class=\"xn-location\">Japan<\/span>\u00a0from the Ministry of Health, Labour and Welfare for Akalux\u00ae IV Infusion 250mg (cetuximab sarotalocan sodium) to treat unresectable locally advanced or recurrent head and neck cancer. \u00a0BioBlade\u00ae Laser System, the medical device used in the combination with Akalux, was also approved on\u00a0<span class=\"xn-chron\">September 2<\/span><sup>nd<\/sup>. <a href=\"https:\/\/www.prnewswire.com\/news-releases\/rakuten-medical-japan-announces-marketing-approval-of-akalux-iv-infusion-250mg-and-bioblade-laser-system-from-the-ministry-of-labour-health-and-welfare-in-japan-for-locoregional-cancer-treatment-301138121.html?tc=eml_cleartime\">Read more&#8230;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SAN MATEO, Calif.,\u00a0Sept. 25, 2020\u00a0\/PRNewswire\/ &#8212; Rakuten Medical Inc. is proud to announce that its wholly owned subsidiary Rakuten Medical [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"template":"","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"class_list":{"0":"post-7442","1":"press_releases","2":"type-press_releases","3":"status-publish","5":"entry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rakuten Medical Japan Announces Marketing Approval of Akalux\u00ae IV Infusion 250mg and BioBlade\u00ae Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment - Rakuten Medical - To conquer cancer.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/09\/25\/7442\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rakuten Medical Japan Announces Marketing Approval of Akalux\u00ae IV Infusion 250mg and BioBlade\u00ae Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment - Rakuten Medical - To conquer cancer.\" \/>\n<meta property=\"og:description\" content=\"SAN MATEO, Calif.,\u00a0Sept. 25, 2020\u00a0\/PRNewswire\/ &#8212; Rakuten Medical Inc. is proud to announce that its wholly owned subsidiary Rakuten Medical [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/09\/25\/7442\/\" \/>\n<meta property=\"og:site_name\" content=\"Rakuten Medical - To conquer cancer.\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-20T04:26:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2021\/02\/RakutenMedical_KV.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2020\\\/09\\\/25\\\/7442\\\/\",\"url\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2020\\\/09\\\/25\\\/7442\\\/\",\"name\":\"Rakuten Medical Japan Announces Marketing Approval of Akalux\u00ae IV Infusion 250mg and BioBlade\u00ae Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment - Rakuten Medical - To conquer cancer.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/#website\"},\"datePublished\":\"2020-09-25T14:10:11+00:00\",\"dateModified\":\"2022-04-20T04:26:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2020\\\/09\\\/25\\\/7442\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2020\\\/09\\\/25\\\/7442\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2020\\\/09\\\/25\\\/7442\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rakuten Medical Japan Announces Marketing Approval of Akalux\u00ae IV Infusion 250mg and BioBlade\u00ae Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/\",\"name\":\"Rakuten Medical - To conquer cancer.\",\"description\":\"Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox\u2122TM technology platform. We are committed to our mission to conquer cancer and aim to achieve a society where cancer patients can lead fulfilling lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rakuten Medical Japan Announces Marketing Approval of Akalux\u00ae IV Infusion 250mg and BioBlade\u00ae Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment - Rakuten Medical - To conquer cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/09\/25\/7442\/","og_locale":"en_US","og_type":"article","og_title":"Rakuten Medical Japan Announces Marketing Approval of Akalux\u00ae IV Infusion 250mg and BioBlade\u00ae Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment - Rakuten Medical - To conquer cancer.","og_description":"SAN MATEO, Calif.,\u00a0Sept. 25, 2020\u00a0\/PRNewswire\/ &#8212; Rakuten Medical Inc. is proud to announce that its wholly owned subsidiary Rakuten Medical [&hellip;]","og_url":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/09\/25\/7442\/","og_site_name":"Rakuten Medical - To conquer cancer.","article_modified_time":"2022-04-20T04:26:18+00:00","og_image":[{"width":1500,"height":900,"url":"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2021\/02\/RakutenMedical_KV.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/09\/25\/7442\/","url":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/09\/25\/7442\/","name":"Rakuten Medical Japan Announces Marketing Approval of Akalux\u00ae IV Infusion 250mg and BioBlade\u00ae Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment - Rakuten Medical - To conquer cancer.","isPartOf":{"@id":"https:\/\/rakuten-med.com\/us\/#website"},"datePublished":"2020-09-25T14:10:11+00:00","dateModified":"2022-04-20T04:26:18+00:00","breadcrumb":{"@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/09\/25\/7442\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/09\/25\/7442\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/09\/25\/7442\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rakuten-med.com\/us\/"},{"@type":"ListItem","position":2,"name":"Rakuten Medical Japan Announces Marketing Approval of Akalux\u00ae IV Infusion 250mg and BioBlade\u00ae Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment"}]},{"@type":"WebSite","@id":"https:\/\/rakuten-med.com\/us\/#website","url":"https:\/\/rakuten-med.com\/us\/","name":"Rakuten Medical - To conquer cancer.","description":"Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox\u2122TM technology platform. We are committed to our mission to conquer cancer and aim to achieve a society where cancer patients can lead fulfilling lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rakuten-med.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/press_releases\/7442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/types\/press_releases"}],"author":[{"embeddable":true,"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/users\/4"}],"wp:attachment":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/media?parent=7442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}